Sutter Health Research Enterprise
2500 Grant Road
Mountain View, CA, 94040
(650) 934-7000
HessleC@pamf.org
Primary Research Interests
Related Clinical Trials
A phase III multicenter, randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with ocrelizumab in adult patients with PPMS
Investigators: Minal Bhanushali MD, PAMFRI Medical Director, David Gershfield MD, Ariele L Greenfield M.D., Director of PAMF Multiple Sclerosis Center, Neurologist and Researcher, Christine Hessler MD
Status: Active, Not Recruiting